TrialBritish journal of haematology2016

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.

Brian G Till et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.